Gene ID | Gene Name | Gene Symbol | Disease Ontology ▲ |
---|---|---|---|
129420905 | heparan sulfate glucosamine 3-O-sulfotransferase 3A1 |
|
|
129418797 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
|
|
129429649 | uronyl 2-sulfotransferase a |
|
|
129451697 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
|
|
129418911 | transmembrane O-mannosyltransferase targeting cadherins 2b |
|
|
129437831 | polypeptide N-acetylgalactosaminyltransferase 17 |
|
|
129437832 | polypeptide N-acetylgalactosaminyltransferase 17-like |
|
|
129451709 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A |
|
|
129439439 | globoside alpha-1,3-N-acetylgalactosaminyltransferase 1-like |
|
|
129422271 | DP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, like |
|
|
129416674 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1-like1 |
|
|
129417693 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9-like |
|
|
129440780 | beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
|
129432245 | glycogen synthase 2 |
|
|
129433777 | UDP-glucuronosyltransferase 2C1-like |
|
|
129453768 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
|
129445004 | UDP-glucuronosyltransferase 2C1-like |
|
|
129443019 | ALG3 alpha-1,3- mannosyltransferase |
|
|
129428195 | UDP-glucuronosyltransferase-like |
|
|
129422166 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
|
129452482 | UDP-glucuronosyltransferase 1-2-like |
|
|
129433778 | UDP-glucuronosyltransferase 2B31-like |
|
|
129447253 | cerebral endothelial cell adhesion molecule |
|
|
129417541 | uronyl 2-sulfotransferase |
|
|
129424154 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024